Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
Clinical trial NCT03469336 · COMPLETED
Trial details
- NCT number
- NCT03469336
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2019-03-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.